Protocol of Multi-domain Attention Training

February 19, 2020 updated by: Yang, Hui-Ling, Ministry of Science and Technology, Taiwan

The Development and Evaluation of Multi-domain Attention Training for Older Adults With Mild Cognitive Impairment

This study sought to investigate the changes in attention in older adults with mild cognitive impairment after Multi-domain Attention Training .

Study Overview

Detailed Description

This double-blind randomized controlled study has a 2-arm parallel group design. All subjects will be randomized by the block randomization, into intervention group (Multi-domain Attention Training, MAT), or active control group (Passive information activities, PIA). Training sessions of the MAT group are 45 minutes/day, 3 days/week, for 12 weeks (36 sessions each). The training of PIA group is the same as MAT group. The investigators constructed a rigorous MAT program adhering to the Consolidated Standards of Reporting Trials (CONSORT) reporting guidelines. The investigators expect to determine the improvement in attention function of older adults with mild cognitive impairment after using the MAT program.

Study Type

Interventional

Enrollment (Anticipated)

60

Phase

  • Not Applicable

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Participants must endorse at least two items from a list of frequent subjective memory complaints by patient and/or an informant
  • Objective memory impairment on neuropsychological tests of memory 1.5 SD or more below age/education norms
  • Clinical neurologic examination by the Mini-Mental State Examination (MMSE) score of 24 or higher
  • No impairment in personal activities of daily living (P-ADL) as determined by clinical interview with participant and family

Exclusion Criteria:

  • The clinical diagnosis of dementia was based on the DSM-IV-TR
  • Active in another cognitive or memory-related training in the past year
  • Comorbid medical conditions that would predispose them to imminent functional decline or cognitive impairment
  • A diagnosis of major neurological or psychiatric illness history and/or behavioral problems that would sufficiently impair performance to make participation impossible
  • Severe losses in vision, hearing, or communicative ability

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Multi-domain Attention Training (MAT)
Training sessions of the MAT group is 45 minutes/day, 3 sessions/week, for 12 weeks (36 sessions).
The training content emphasis three concept of attention include: intensity of attention, executive attention, and spatial orienting attention.
Other Names:
  • Attention training
Active Comparator: Passive information activities (PIA)
The training sessions of PIA is the same as MAT group (45 min/day, 3 days/week, for 12 weeks, for a total of 36 sessions).
The active control group (Passive information activities) training content included reading online e-books and playing online games.
Other Names:
  • Active control group

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in attention as measured by the Digit Span Task (DS).
Time Frame: Change from baseline in executive attention at Immediate post-test, 3 months, 6 months after intervention.
The primary outcome indicators is executive attention assessed by the Digit Span Task (DS).
Change from baseline in executive attention at Immediate post-test, 3 months, 6 months after intervention.

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in attention as measured by the Trail Making Test (TMT).
Time Frame: Change from baseline in spatial orienting attention at Immediate post-test, 3 months, 6 months after intervention.
The secondary outcome indicator is spatial orienting attention evaluated by the Trail Making Test.
Change from baseline in spatial orienting attention at Immediate post-test, 3 months, 6 months after intervention.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

August 1, 2016

Primary Completion (Actual)

May 31, 2019

Study Completion (Actual)

December 31, 2019

Study Registration Dates

First Submitted

December 10, 2017

First Submitted That Met QC Criteria

December 18, 2017

First Posted (Actual)

December 20, 2017

Study Record Updates

Last Update Posted (Actual)

February 20, 2020

Last Update Submitted That Met QC Criteria

February 19, 2020

Last Verified

February 1, 2020

More Information

Terms related to this study

Other Study ID Numbers

  • N201602069

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Mild Cognitive Impairment

Clinical Trials on Multi-domain Attention Training (MAT)

3
Subscribe